主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
FBLG
#3765
FibroBiologics, Inc. Common Stock
0.3
3
+17.86%
版块:
基础:
利润货币:
日范围
年范围
日变化
+17.86%
每月变动
-8.33%
6个月变化
-45.90%
年变化
-72.73%
前一天收盘价
0.2
8
Open
0.3
3
Bid
Ask
Low
0.3
3
High
0.3
3
交易量
3
市场
股票
医疗保健
FBLG
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
新闻
H.C. Wainwright, FibroBiologics hisse hedefini 4 dolara düşürdü
H.C. Wainwright cuts FibroBiologics stock price target to $4
FibroBiologics hissedarları ters hisse bölünmesini onayladı
FibroBiologics shareholders approve reverse stock split and warrant share issuances
FibroBiologics, Nasdaq’tan listeleme kuralları için ek süre aldı
FibroBiologics gets Nasdaq extension to meet listing rules
FibroBiologics 2026’nın İlk Çeyreğinde Diyabetik Ayak Ülseri Klinik Deneyine Başlayacak
FibroBiologics to begin diabetic foot ulcer clinical trial in Q1 2026
FibroBiologics disk dejenerasyonu tedavisi için olumlu sonuçlar bildirdi
FibroBiologics reports positive results for disc degeneration therapy
FibroBiologics Nasdaq’tan borsa kotundan çıkarılma bildirimi aldı, itiraz için duruşma talep etti
FibroBiologics receives Nasdaq delisting notice, requests hearing to appeal